Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis with Insights for Periprocedural Management

Brent Hiramoto, Thomas R. McCarty, Nayna A. Lodhia, Andrew Jenkins, Ahmed Elnaiem, Mayssan Muftah, Ryan Flanagan, Walter W. Chan

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

INTRODUCTION: Divergent recommendations for periprocedural management of glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1 RA) medications rely on limited evidence. We performed a systematic review and meta-analysis to provide quantitative measures of gastric emptying relevant to mechanisms of weight loss and to periprocedural management of GLP-1 RA. We hypothesized that the magnitude of gastric emptying delay would be low and of limited clinical significance to procedural sedation risks.

METHODS: A protocolized search identified studies on GLP-1 RA that quantified gastric emptying measures. Pooled estimates using random effects were presented as a weighted mean difference with 95% confidence intervals (CIs). Univariate meta-regression was performed to assess the influence of GLP-1 RA type, short-acting vs long-acting mechanism of action, and duration of treatment on gastric emptying.

RESULTS: Fifteen studies met the inclusion criteria. Five studies (n = 247) utilized gastric emptying scintigraphy. Mean T 1/2 was 138.4 minutes (95% CI 74.5-202.3) for GLP-1 RA vs 95.0 minutes (95% CI 54.9-135.0) for placebo, with a pooled mean difference of 36.0 minutes (95% CI 17.0-55.0, P < 0.01, I2 = 79.4%). Ten studies (n = 411) utilized the acetaminophen absorption test, with no significant delay in gastric emptying measured by T max , area under the curve (AUC) 4hr , and AUC 5hr with GLP-1 RA ( P > 0.05). On meta-regression, the type of GLP-1 RA, mechanism of action, and treatment duration did not impact gastric emptying ( P > 0.05).

DISCUSSION: While a gastric emptying delay of ∼36 minutes is quantifiable on GLP-1 RA medications, it is of limited magnitude relative to standard periprocedural fasting periods. There were no substantial differences in gastric emptying on modalities reflective of liquid emptying (acetaminophen absorption test), particularly at time points relevant to periprocedural care.

Original languageEnglish (US)
Pages (from-to)1126-1140
Number of pages15
JournalAmerican Journal of Gastroenterology
Volume119
Issue number6
DOIs
StatePublished - Jun 1 2024

Keywords

  • GLP-1 receptor agonist
  • gastric emptying delay
  • gastric emptying scintigraphy
  • pre-procedure care
  • procedural sedation
  • Weight Loss/drug effects
  • Gastric Emptying/drug effects
  • Glucagon-Like Peptide 1
  • Humans
  • Glucagon-Like Peptide-1 Receptor/agonists
  • Perioperative Care/methods
  • Hypoglycemic Agents/therapeutic use

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis with Insights for Periprocedural Management'. Together they form a unique fingerprint.

Cite this